Cubist Systematic Strategies’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Cubist Systematic Strategies’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-135,120	Closed	-$1.22M	–	4147
2023 Q2	$1.22M	Buy	135,120 +116,275	+617%	+$1.03M	0.01%	1838
2023 Q1	$137K	Sell	18,845 -34,861	-65%	-$259K	﹤0.01%	3374
2022 Q4	$392K	Sell	53,706 -34,378	-39%	-$255K	﹤0.01%	3186
2022 Q3	$681K	Buy	88,084 +86,484	+5,405%	+$734K	﹤0.01%	2929
2022 Q2	$11K	Sell	1,600 -32,296	-95%	-$247K	﹤0.01%	4265
2022 Q1	$270K	Buy	+33,896	New	+$215K	﹤0.01%	2899
2021 Q4	–	Sell	-3,637	Closed	-$28K	–	3699
2021 Q3	$28K	Buy	+3,637	New	+$33.2K	﹤0.01%	2875

Other funds holding PNT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's PNT Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2023, closing a stake of 135,120 shares — an estimated $1.22M sold.

Cubist Systematic Strategies first reported a position in PNT in Q3 2021 and held it in 7 quarters. The position peaked at $1.22M in Q2 2023. 125 funds tracked by Wall St. Rank hold PNT as of Q3 2023.

Cubist Systematic Strategies reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 135,120 POINT Biopharma Global Inc. Common Stock shares in Q3 2023, an estimated $1.22M.
Cubist Systematic Strategies first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Cubist Systematic Strategies's POINT Biopharma Global Inc. Common Stock position peaked at $1.22M in Q2 2023.
125 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.